Nasus Pharma Ltd balance sheet

At the end of fiscal 2025, Nasus Pharma Ltd had total assets of $5.0m, total liabilities of $2.2m and shareholders' equity of $2.8m. It held $1.2m in cash against $0 of debt: net cash of $1.2m.

Balance sheet

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Nasus Pharma Ltd: balance sheet, annual
Fiscal year	2025Dec 2025
Cash and equivalents	1,237
Total current assets	4,855
Total assets	5,004
Accounts payable	829
Total current liabilities	2,163
Total debt	0
Total liabilities	2,236
Shareholders' equity	2,768
Net debt (negative = net cash)	−1,237
Shares outstanding	9m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: NSRX vs TRLV INDV vs NSRX NSRX vs PBH

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Nasus Pharma Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Nasus Pharma Ltd.